English Deutsch 中文
  • Innovative Solutions
  • Expert Support and Knowledge
  • Reliable Cooperation
Menu Deutsch 中文

Guangxi Wuzhou Invests in Two Israeli Companies

Dec. 11, 2014

On December 11, 2014 Integra Holdings, the biotechnology holdings company of Yissum, the technology transfer company of the Hebrew University of Jerusalem, announced that it has received US$3 million investment from Guangxi Wuzhou Pharmaceutical Group Co., Ltd., a subsidiary of the Guangxi Wuzhou Zongheng Group, a Chinese investment holdings company. The funds raised will be used to advance Integra Holdings' existing portfolio companies and to create new companies, based on promising projects originating from the Hebrew University.

Earlier in the month, on December 3, 2014, Israeli Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced that it has received $5 million in connection with the definitive agreement with Guangxi Wuzhou Pharma for the purchase of restricted shares of its common stock in a private placement.